BioSpace News Archive

Policy

IDx Founder Awarded Patent for System that Automatically Detects Measure of Cardiovascular Health

Patented tool will aid development of an algorithm that identifies patients at high risk of cardiovascular events.

March 29, 2018
·
2 min read
Business

Motus GI Announces 2017 Financial Results and Provides Business Outlook

Successfully completed $17.5M IPO and listed on NASDAQ Capital Market.

March 29, 2018
·
10 min read
FDA

Scholar Rock Granted Orphan Drug Designation by the FDA for SRK-015 for the Treatment of Patients with Spinal Muscular Atrophy

SRK-015 is an inhibitor of the activation of myostatin, which Scholar Rock believes has the potential to be the first muscle-directed therapy to reverse or prevent muscle atrophy in SMA patients.

March 29, 2018
·
5 min read
Business

AngioDynamics Reports Fiscal 2018 Third Quarter Financial Results

FDA granted Breakthrough designation to NanoKnife® System for the treatment of Stage III pancreatic cancer.

March 29, 2018
·
18 min read
Business

Aldeyra Therapeutics Announces Year End 2017 Financial Results

Aldeyra Therapeutics, Inc. announced financial results for the year ended December 31, 2017.

March 29, 2018
·
7 min read
Genetown

Biostage awarded SBIR Fast-Track grant to develop Cellspan™ Esophageal Implant (CEI) as a novel treatment for esophageal atresia in pediatric patients

Biostage, Inc. announced it has been awarded a Fast-Track Small Business Innovation Research (SBIR) grant by the Eunice Kennedy National Institute of Child Health and Human Development (NICHD).

March 29, 2018
·
2 min read
Deals

Genprex Announces Pricing of Initial Public Offering of Common Stock

Genprex, Inc. announced the pricing of its initial public offering on March 28, 2018 of an aggregate of 1,280,000 shares of common stock at a public offering price of $5.00 per share, before underwriting discounts.

March 29, 2018
·
2 min read
Drug Development

Stellar Biotech Begins Scale-Up and Expansion Project at Port Facility

Stellar Biotechnologies, Inc. initiated the second phase of an expansion project at the Port of Hueneme, north of Los Angeles, California.

March 29, 2018
·
3 min read
Drug Development

Abbott Initiates Trial to Evaluate Improved Survival And Outcomes with the CardioMEMS Monitor

Abbott announced today the company has initiated the landmark GUIDE-HF clinical trial using the CardioMEMS™ HF System.

March 29, 2018
·
3 min read
Biotech Beach

Inari Medical Announces Completion of $27 Million Series C Financing

Inari Medical, Inc. announced today the close of a Series C financing totaling $27.0 million.

March 29, 2018
·
2 min read